Ads
related to: endometrioid carcinoma treatment- EC Treatment Options
Learn About An Endometrial Cancer
Treatment Option For Your Patients.
- EC Treatment Information
Read About A Type Of EC Treatment
And View Treatment Information.
- Explore The Clinical Data
Of A Personalized EC Treatment
To See Clinical Trial Results.
- Access & Support Options
Explore The Options Together
In One Easy-To-Access Location.
- See The Lab Abnormalities
And Safety Info Of A Clinical Trial
Learn More About An EC Treatment.
- Dosing Information
Get The Dosing & Administration
Information For An EC Treatment.
- EC Treatment Options
Search results
Results From The WOW.Com Content Network
Ovarian endometrioid tumors are part of the surface epithelial tumor group of ovarian neoplasms (10–20% of which are the endometrioid type). Benign and borderline variants are rare, as the majority are malignant. There is an association with endometriosis and concurrent primary endometrial carcinoma (endometrial cancer).
The most frequent type of endometrial cancer is endometrioid carcinoma, which accounts for more than 80% of cases. [3] Endometrial cancer is commonly diagnosed by endometrial biopsy or by taking samples during a procedure known as dilation and curettage. [1] A pap smear is not typically sufficient to show endometrial cancer. [4]
Treatment of uterine cancer may differ depending on the type of cancer and staging of the tumor. [15] In early stages, minimal invasive surgery is preferred. [16] For endometrial cancer, five main types of treatments are used, including surgery, radiation therapy, chemotherapy, hormone therapy, and targeted therapy
It is composed of a collection of abnormal endometrial cells, arising from the glands that line the uterus, which have a tendency over time to progress to the most common form of uterine cancer—endometrial adenocarcinoma, endometrioid type.
Uterine clear-cell carcinoma (CC) is a rare form of endometrial cancer with distinct morphological features on pathology; it is aggressive and has high recurrence rate. Like uterine papillary serous carcinoma CC does not develop from endometrial hyperplasia and is not hormone sensitive, rather it arises from an atrophic endometrium.
Uterine serous carcinoma is a malignant form of serous tumor that originates in the uterus. It is an uncommon form of endometrial cancer that typically arises in postmenopausal women. It is typically diagnosed on endometrial biopsy , prompted by post-menopausal bleeding .
Ads
related to: endometrioid carcinoma treatment